"Drug companies, not elderly Americans, are the real beneficiaries of the new Medicare prescription drug plan," the press release declares. For Big Pharma companies in the US, the headline is all too familiar: It could appear on a proclamation issued by Democratic critics of the new Part D benefit, a policy paper commissioned by Public Citizen, or an angry letter to the editor in almost any newspaper across the country.
But the press release didn’t come from one of the usual suspects. It didn’t even come from the US. The...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?